Anne Wojcicki’s nonprofit has successfully reacquired 23andMe for $305 million, taking the genetic testing pioneer private after its bankruptcy. The move aims to refocus its mission away from public pressures, despite ongoing legal challenges from states regarding genetic data privacy.